Latest: FDA Approves New Biosimilar for Oncology Treatment
Neurology

Vormatrigine Reduces Seizures in Phase 2 RADIANT Study, Postpartum Depression in MS Women, Ianalumab Produces Significant Phase 3 Data in Sjögren’s disease

by Neurology Live
0 Comments
0 Mins
Neurology News Network. for the week ending August 16, 2025. [WATCH TIME: 4 minutes]
Tags:
Neurology Live
Author

Neurology Live

Previous Post
Think tonsillitis is just for kids? Think again - Harvard Health
Next Post
Using AI, Socioeconomic Factors to Predict Outcomes After Allo-SCT for AML
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago